Evidence map›Paper›PMID 40115784›Full record

ArticleFrontiers in medicine2025

Association between life's crucial 9 and kidney stones: a population-based study.

Xiao-Ran Li, Han-Lin Liu, Li Wang, Jian-Wei Yang, Kang-Yu Wang, Si-Yu Chen, Li Yang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Life's Crucial 9 Score as a Novel Role for Chronic Obstructive Pulmonary Disease Screening.International journal of chronic obstructive pulmonary disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao-Ran Li *The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Han-Lin Liu *The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Li Wang *The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Jian-Wei YangThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Kang-Yu WangThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Si-Yu ChenThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Li YangThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study examined the association between the Life's Crucial 9 (LC9) score and kidney stone prevalence in U.S. adults. Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2014, this cross-sectional analysis focused on adult participants with kidney stone onset or recurrence. LC9 scores were divided into four quartiles for analysis. Weighted multivariable logistic regression, restricted cubic spline (RCS) modeling, threshold effect analysis, and subgroup analyses were employed to evaluate the relationship between LC9 scores and kidney stone prevalence. Results: The study included 24,669 participants with an average age of 46.05 ± 0.34 years and a mean LC9 score of 73.76 ± 0.25. The overall prevalence of kidney stones was 8.45%, while the average recurrence rate stood at 2.96%. Importantly, for each one-point increase in the LC9 score, the incidence of kidney stones dropped by 1.2% (95% CI: 0.979 to 0.997, Conclusion: An elevated LC9 score correlates with a lower risk of both kidney stone formation and recurrence. Maintaining an optimal LC9 score could be an effective approach for preventing kidney stones.

Indexed as

cardiovascular healthdepressionkidney stoneLife’s crucial 9NHANSE

Identifiers

PMID40115784
PMCPMC11922861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.